2019 • 2018 • 2017 • 2016 • 2015 • 2014 • 2013 • 2012 • 2011 • 2010
2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000
— 2012 —
Ahmed SA, Awosika J, Baldwin C, Bishop-Lilly KA, Biswas B, Broomall S, Chain PSG, Chertkov O, Chokoshvili O, Coyne S, Davenport K, Detter JC, Dorman W, Erkkila TH, Folster JP, Frey KG, George M, Gleasner C, Henry M, Hill KK, Hubbard K, Insalaco J, Johnson S, Kitzmiller A, Krepps M, Lo CC, Luu T, McNew LA, Minogue T, Munk CA, Osborne B, Patel M, Reitenga KG, Rosenzweig CN, Shea A, Shen XH, Strockbine N, Tarr C, Teshima H, van Gieson E, Verratti K, Wolcott M, Xie G, Sozhamannan S, Gibbons HS. Genomic comparison of Escherichia coli O104:H4 isolates from 2009 and 2011 reveals plasmid and prophage heterogeneity including Shiga Toxin encoding phage stx2. PLoS One 2012, 7(11): e48228
Akhvlediani T, Chitadze N, Laws TR, Makharadze M, Chubinidze M, Tsanava S, Commander NJ, Perkins SD, Dyson EH, Rivard RG, Hepburn MJ, Simpson AJH, Imnadze P, Trapaidze N. Comparison of total antibody and interferon-? T-cell responses in patients following infection with brucellosis in Georgia. Journal of Infection and Public Health 2012 Oct, 5(5): 321-331
Arrigo NC, Briese T, Calisher CH, Drebot MA, Fljelle B, LeDuc JW, Powers AM, Repik PM, Roehrig JT, Schmaljohn CS, Tesh RB, Weaver SC. Recommendations for Publication of Viral Genetic Data and Sample Access for Novel Viruses and Strains American Journal of Tropical Medicine and Hygiene 2012 Feb, 86(2): 189-191
Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, Liu T, Keuhne AI, Li S, Woods VL Jr, Chandran K, Dye JM, Saphire EO. Structural basis for differential neutralization of ebolaviruses. Viruses. 2012 Apr, 4(4): 447-70
Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine 2012 Mar 2; 30(11): 1951-1958
Bozue J, Cote CK, Webster W, Bassett A, Tobery S, Little S, Swietnicki W. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice. FEMS Microbiology Letters 2012 July, 332(2): 113-121
Bozue J, Powell BS, Cote CK, Moody KL, Gelhaus HC, Vietri NJ, Rozak DA. Disrupting the luxS quorum sensing gene does not significantly affect Bacillus anthracis virulence in mice or guinea pigs. Virulence 2012 Oct, 3(6): 504-509
Brocato R, Josleyn M, Ballantyne J, Vial P, Hooper JW. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS). PLoS One 2012, 7(4): e35996
Bryce L, Koenig M, Jerke KH. A large-scale study of respiratory virus infection over 2 years using the Luminex xTAGRVP assay. Military Medicine 2012 Dec, 177(12): 1533-1538
Buzard GS, Baker D, Wolcott MJ, Norwood DA, Dauphin LA. Multi-platform comparison of ten commercial master mixes for probe-based real-time polymerase chain reaction detection of bioterrorism threat agents for surge preparedness. Forensic Science International 2012 Nov, 223 (1-3): 292-297
Byers DM, Gorbet JC, Irwin LN. Disialogangliosides and TNFα alter gene expression for cytokines and chemokines in primary brain cell cultures. Neurochemical Research 2012 Jan, 37(1): 214-222
Cardellina JH, Roxas-Duncan VI, Montgomery V, Eccard V, Campbell Y, Hu X, Khavrutskii I, Tawa GJ, Wallqvist A, Gloer JB, Phatak NL, Hoeller U, Soman AG, Joshi BK, Hein SM, Wicklow DT, Smith LA. Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A. ACS Medicinal Chemistry Letters 2012 May, 3(5): 387-391
Chabot DJ, Joyce J, Caulfield M, Cook J, Hepler R, Wang S, Vietri NJ, Ruthel G, Shoop W, Pitt L, Leffel E, Ribot W, Friedlander AM. Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys Vaccine Jan 20, 30(5): 846-52
Chaudhury S, Olson MA, Tawa G, Wallqvist A, Lee MS. Efficient Conformational Sampling in Explicit Solvent Using a Hybrid Replica Exchange Molecular Dynamics Method. Journal of Chemical Theory and Computation 2012 Feb, 8(2): 677-687
Cisney ED, Fernandez S, Hall SI, Krietz GA, Ulrich RG. Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines. Journal of Visualized Experiments 2012 Aug 1, (66): 3960
Cote CK, Kaatz L, Reinhardt J, Bozue J, Tobery SA, Bassett AD, Sanz P, Darnell SC, Alem F, O'Brien AD, Welkos SL. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia. Journal of Medical Microbiology 2012 Oct, 61(10): 1380-92
Dabisch P, Yeager J, Kline J, Klinedinst K, Welsch A, Pitt ML. Comparison of the efficiency of sampling devices for aerosolized Burkholderia pseudomallei. Inhalation Toxicology 2012 Apr, 24(5): 247-254
Del Favero G, Florio C, Codan B, Sosa S, Poli M, Sbaizero O, Molg� J, Tubaro A, Lorenzon P. The stretch-activated channel blocker Gd 3+ reduces palytoxin toxicity in primary cultures of skeletal muscle cells. Chemical Research in Toxicology 2012 Sept 17, 25(9): 1912-1920
Del Favero G, Sosa S, Pelin M, D'Orlando E, Florio C, Lorenzon P, Poli M, Tubaro A. Sanitary problems related to the presence of Ostreopsis spp, in the Mediterranean Sea: A multidisciplinary scientific approach. Annali dell�Istituto Superiore di Sanita 2012, 48(4): 407-414
Do Y, Didierlaurent AM, Ryu S, Koh H, Park CG, Park S, Perlin DS, Powell BS, Steinman RM. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor. Vaccine. 2012 Oct 5, 30(45): 6359-67
Dower K, Filone CM, Hodges EN, Bjornson ZB, Rubins KH, Brown LE, Schaus S, Hensley LE, Connor JH. Identification of a Pyridopyrimidinone Inhibitor of Orthopoxviruses from a Diversity-Oriented Synthesis Library. Journal of Virology 2012 Mar, 86(5): 2632-2640
Dupuy LC, Reed DS. Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives. Current Opinion in Virology 2012 June 2012, 2(3): 363-7
Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Ortiz RA, Prugar LI, Pratt WD. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proceedings of the National Academy of Sciences of the USA 2012 Mar 27, 109(13): 5034-5039
Edupuganti OP, Ovsepian SV, Wang J, Zurawski TH, Schmidt JJ, Smith L, Lawrence GW, Dolly JO. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin. FEBS Journal 2012 July, 279(14): 2555-2567
Eppinger M, Radnedge L, Andersen G, Vietri N, Severson G, Mou S, Ravel J, Worsham PL. Novel Plasmids and Resistance Phenotypes in Yersinia pestis: Unique Plasmid Inventory of Strain Java 9 Mediates High Levels of Arsenic Resistance. PLoS One 2012, 7(3): e32911
Erwin-Cohen RA, Porter AI, Pittman PR, Rossi CA, DaSilva L. Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): Comparison of na�ve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells. Human Vaccines and Immunotherapeutics 2012 Aug, 8(8): 1053-1065
Fenimore PW, Muhammad MA, Fischer WM, Foley BT, Bakken RR, Thurmond JR, Yusim K, Yoon H, Parker M, Hart MK, Dye JM, Korber B, Kuiken C. Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage. PLoS One 2012, 7(10): e44769
Fisher NA, Ribot WJ, Applefeld W, Deshazer D. The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis. BMC Microbiology 2012 June 22, 12: 117
Forsberg LS, Abshire TG, Friedlander A, Quinn CP, Kannenberg EL, Carlson RW. Localization and structural analysis of a conserved pyruvylated epitope in Bacillus *anthracis* secondary cell wall polysaccharides and characterization of the galactose-deficient wall polysaccharide from avirulent B-*anthracis* CDC 684. Glycobiology 2012 Aug, 22(8): 1103-1117
Friedrich BM, Trefry JC, Biggins JE, Hensley LE, Honko AN, Smith DR, Olinger GG. Potential vaccines and post-exposure treatments for filovirus infections. Viruses 2012 Sept, 4(9): 1619-1650
Fuller T, Thomassen HA, Mulembakani PM, Johnston SC, Lloyd-Smith JO, Kisalu NK, Lutete TK, Blumberg S, Fair JN, Wolfe ND, Shongo RL, Formenty P, Meyer H, Wright LL, Muyembe JJ, Buermann W, Saatchi SS, Okitolonda E, Hensley L, Smith TB, Rimoin AW. Using Remote Sensing to Map the Risk of Human Monkeypox Virus in the Congo Basin. Ecohealth 2012 Mar 5, 8(1):14-25
Gaidamakova EK, Myles IA, McDaniel DP, Fowler CJ, Valdez PA, Naik S, Gayen M, Gupta P, Sharma A, Glass PJ, Maheshwari RK, Datta SK, Daly MJ. Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio-protective Mn2+-Peptide complex from Deinococcus. Cell Host & Microbe 2012 July 19, 12(1): 117-24
Golden JW, Josleyn M, Mucker EM, Hung C-F, Loudon PT, Wu TC, Hooper JW. Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates. PLoS One 2012 7(7): e42353
Grant-Klein RJ, Van Deusen NM, Badger CV, Hannaman D, Dupuy LC, Schmaljohn CS. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge. Human Vaccines & Immunotherapeutics 2012 Nov, 8(11): 1703-1706
Hale M. Near infrared whole body imaging. Botulinum Journal 2012, 2(2): 168-172
Hale ML, Cai S, Ahmed SA. Medical applications of clostridia and clostridial toxins. Journal of Toxicology 2012, 2012: 678963
Hart MK, Saviolakis GA, Welkos SL, House RV. Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges. Advances in Preventive Medicine 2012 2012: 731604
Higa MM, Petersen J, Hooper J, Doms RW. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies. Virology 2012 Feb 20, 423(2): 134-142
Hines HB. Microbial proteomics using mass spectrometry. Methods in Molecular Biology 2012, 881: 159-186
Hoke CH, Pace-Templeton J, Pittman P, Malinoski FJ, Gibbs P, Ulderich T, Mathers M, Fogtman B, Glass P, Vaughn DW. US Military contributions to the global response to pandemic Chikungunya. Vaccine 2012 Oct 19, 30(47): 6713 - 6720
Hu X, Legler PM, Khavrutskii I, Scorpio A, Compton JR, Robertson KL, Friedlander AM, Wallqvist A. Probing the Donor and Acceptor Substrate Specificity of the gamma-Glutamyl Transpeptidase. Biochemistry 2012 Feb 14, 51(6): 1199-1212
Iversen PL, Warren TK, Wells JB, Garza NL, Mourich DV, Welch LS, Panchal RG, Bavari S. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses 2012 Nov, 4(11): 2806-2830
Jiang J, You BJ, Liu E, Apte A, Yarina TR, Myers TE, Lee JS, Francesconi SC, O'Guinn ML, Tsertsvadze N, Vephkhvadze N, Babuadze G, Sidamonidze K, Kokhreidze M, Donduashvili M, Onashvili T, Ismayilov A, Agayev N, Aliyev M, Muttalibov N, Richards AL. Development of three quantitative real-time PCR assays for the detection of Rickettsia raoultii Rickettsia slovaca and Rickettsia aeschlimannii and their validation with ticks from the country of Georgia and the Republic of Azerbaijan. Ticks and Tick-Borne Diseases 2012 Dec, 3(5-6): 326-330
Jing X, Robinson HR, Heffron JD, Popham DL, Schubot FD. The catalytic domain of the germination-specific lytic transglycosylase SleB from Bacillus anthracis displays a unique active site topology. Proteins: Structure, Function and Bioinformatics 2012 Oct: 80(10): 2469 - 2475
Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A, Hensley LE. In vitro inhibition of monkeypox virus production and spread by Interferon-beta. Virology Journal 2012 Jan 6, 9: 5
Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, Helma CH, Hill K, Kull S, Kirchner S, Dorner MB, Dorner BG, Pirkle JL, Barr JR. De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Analytical & Bioanalytical Chemistry 2012 Apr, 403(1): 215-26
Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, Smith LA, Fernandez R, Raphael BH, Maslanka SE, Pirkle JL, Barr JR. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Letters 2012 Jan 20, 586(2): 109-115
Kissner TL, Ruthel G, Alam S, Mann E, Ajami D, Rebek M, Larkin E, Fernandez S, Ulrich RG, Ping S, Waugh DS, Rebek J, Saikh KU. Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88. PLoS One 2012 7(7): e40773
Kota KP, Benko JG, Mudhasani R, Retterer C, Tran JP, Bavari S, Panchal RG. High content image based analysis identifies cell cycle inhibitors as regulators of ebola virus infection. Viruses 2012 Sept 25, 4(10): 1865 - 1877
Krakauer T. PI3K/Akt/mTOR a pathway less recognized for staphylococcal superantigen-induced toxicity. Toxins 2012 Nov 15, 4(11): 1343-1366
Krakauer T, Buckley M. Intranasal rapamycin rescues mice from staphylococcal enterotoxin B-induced shock. Toxins 2012 Sept, 4(9): 718-728
Krishnan A, Miller EH, Herbert AS, Ng M, Ndungo E, Whelan SP, Dye JM, Chandran K. Niemann-Pick C1 (NPC1)/NPC1-like1 Chimeras define sequences critical for NPC1's function as a Filovirus entry receptor. Viruses 2012 Nov, 4(11): 2471-2484
Kugelman JR, Lee MS, Rossi CA, McCarthy SE, Radoshitzky SR, Dye JM, Hensley LE, Honko A, Kuhn JH, Jahrling PB, Warren TK, Whitehouse CA, Bavari S, Palacios G. Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection. PLoS One, 7(11): e50316
Kumar G, Kumaran D, Ahmed SA, Swaminathan S. Peptide inhibitors of botulinum neurotoxin serotype A: Design inhibition cocrystal structures structure-activity relationship and pharmacophore modeling. Acta Crystallographica Section D: Biological Crystallography 2012 May; 68(5): 511-520
Kvitko BH, Cox CR, DeShazer D, Johnson SL, Voorhees KJ, Schweizer HP. phi X216 a P2-like bacteriophage with broad Burkholderia pseudomallei and B, mallei strain infectivity. BMC Microbiology 2012 Dec 7, 12: 289
Lebeda FJ, Dembek ZF, Adler M. Kinetic and reaction pathway analysis in the application of botulinum toxin a for wound healing. Journal of Toxicology 2012, 2012: 159726
Lindsey CY, Powell BS, Bolt CR, Brown JE, Adamovicz JJ. Validation of quantitative ELISAs for measuring anti-yersinia pestis F1 and V antibody concentrations in nonhuman primate sera. Journal of Immunoassay & Immunochemistry 2012 Jan; 33 (1): 91-113
Louie A, VanScoy BD, Brown DL, Kulawy RW, Heine HS, Drusano GL. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Antimicrobial Agents and Chemotherapy 2012 Mar, 56(3): 1229-1239
Louie A, VanScoy BD, Heine HS, Liu W, Abshire T, Holman K, Kulawy R, Brown DL, Drusano GL. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in Vitro pharmacodynamic system. Antimicrobial Agents and Chemotherapy 2012 Mar, 56(1): 513-517
McLain DE, Lewis BS, Chapman JL, Wannemacher RW, Lindsey CY, Smith LA. Protective Effect of Two Recombinant Ricin Subunit Vaccines in the New Zealand White Rabbit Subjected to a Lethal Aerosolized Ricin Challenge: Survival Immunological Response and Histopathological Findings. Toxicological Sciences 2012 Mar, 126(1): 72-83
Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne A,I Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO Journal 2012 Apr 18 31(8): 1947-1960
Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW. Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates. PLoS Neglected Tropical Diseases 2012 Mar, 6(3): e1567
Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Cote M, Sullivan N, Fabozzi G, Hensley L, Cunningham J. Filoviruses Require Endosomal Cysteine Proteases for Entry but Exhibit Distinct Protease Preferences. Journal of Virology 2012 Mar, 86(6): 3284-3292
Mizanur RM, Gorbet J, Swaminathan S, Ashraf Ahmed S. Inhibition of catalytic activities of botulinum neurotoxin light chains of serotypes A B and E by acetate sulfate and calcium. International Journal of Biochemistry and Molecular Biology 2012, 3( 3 ): 313-321
Mou S, Cote CK, Worsham PL. Cytotoxic necrotizing factor is an effective immunogen in a Yersinia pseudotuberculosis aerosol mouse model. Advances in Experimental Medicine and Biology 2012, 954: 179-181
Mukherjee J, Tremblay JM, Leysath CE, Ofori K, Baldwin K, Feng XC, Bedenice D, Webb RP, Wright PM, Smith LA, Tzipori S, Shoemaker CB. A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model. PLoS One 2012, 7(1): e29941
Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, Guendel I, Das R, Baer A, Bethel L, Turell M, Hartman AL, Das B, Bailey C, Kashanchi F. Curcumin inhibits rift valley fever virus replication in human cells. Journal of Biological Chemistry 2012 Sept 28, 287(40): 33198-33214
Ngundi MM, Meade BD, Little SF, Quinn CP, Corbett CR, Brady RA, Burns DL. Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action. Clinical and Vaccine Immunology 2012 May, 19(5): 731-739
Nygaard RM, Golden JW, Schiff LA. Impact of host proteases on reovirus infection in the respiratory tract. Journal of Virology 2012 Jan, 86(2): 1238-1243
Olal D, Kuehne AI, Bale S, Halfmann P, Hashiguchi T, Fusco ML, Lee JE, King LB, Kawaoka Y, Dye JM, Saphire EO. Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus. Journal of Virology 2012 Mar, 86(5): 2809-2816
Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the Naitonal Academy of Sciences of the USA. 2012 Oct 30, 109(44): 18030-18035
Opsenica I, Filipovic V, Nuss JE, Gomba LM, Opsenica D, Burnett JC, Gussio R, Solaja BA, Bavari S. The synthesis of 25-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease. European Journal of Medicinal Chemistry 2012 July 53: 374-379
Panchal RG, Geller BL, Mellbye B, Lane D, Iversen PL, Bavari S. Peptide Conjugated Phosphorodiamidate Morpholino Oligomers Increase Survival of Mice Challenged with Ames Bacillus anthracis. Nucleic Acid Therapeutics 2012 Oct, 22 (5): 316-322
Panchal RG, Reid SP, Tran JP, Bergeron AA, Wells J, Kota KP, Aman J, Bavari S. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Antiviral Research 2012 Jan, 93(1): 23-9
Pegoraro G, Bavari S, Panchal RG. Shedding light on filovirus infection with high-content imaging. Viruses 2012 Aug, 4(8): 1354-71
Pelin M, Sosa S, Della Loggia R, Poli M, Tubaro A, Decorti G, Florio C. The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. Food and Chemical Toxicology 2012 Feb: 50(2): 206-211
Powell BS, Lazarev AV, Carlson G, Ivanov AR, Rozak DA. Pressure cycling technology in systems biology. Methods in Molecular Biology 2012 881: 27-62
Radoshitzky SR, Kuhn JH, de Kok-Mercado F, Jahrling PB Bavari S. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opinion on Drug Discovery 2012 July 7(7): 613-32
Reed C, Steele KE, Honko A, Shamblin J, Hensley LE, Smith DR. Ultrastructural study of Rift Valley fever virus in the mouse model. Virology 2012 Sept 15 431(1-2): 58-70
Reid StP, Shurtleff AC, Bavari S. Emerging therapeutic options against filoviruses. Drugs of the Future 2012 May 37(5): 343-351
Reinbold-Wasson DD, Sardelis MR, Jones JW, Watts DM, Fernandez R, Carbajal F, Pecor JE, Calampa C, Klein TA, Turell MJ. Determinants of Anopheles Seasonal Distribution Patterns Across a Forest to Periurban Gradient near Iquitos Peru. American Journal of Tropical Medicine and Hygiene 2012 Mar, 86(3): 459-463
Reisler RB, Gibbs PH, Danner DK, Boudreau EF. Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: Eastern equine and western equine encephalitis. Vaccine 2012 Nov 26, 30 (50): 7271-7277
Reisler RB, Smith LA. The need for continued development of ricin countermeasures. Advances in Preventive Medicine 2012: 149737
Ridnour LA, Barasch KM, Windhausen AN, Dorsey TH, Lizardo MM, Yfantis HG, Lee DH, Switzer CH, Cheng RYS, Heinecke JL, Brueggemann E, Hines HB, Khanna C, Glynn SA, Ambs S, Wink DA. Nitric oxide synthase and breast cancer: Role of TIMP-1 in NO-mediated Akt activation. PLoS One 2012, 7(9): e44081
Romero R, Soto E, Berry SM, Hassan SS, Kusanovic JP, Yoon BH, Edwin S, Mazor M, Chaiworapongsa T. Blood pH and gases in fetuses in preterm labor with and without systemic inflammatory response syndrome. Journal of Maternal-Fetal and Neonatal Medicine 2012 July, 25(7): 1160-70
Ross TM, Bhardwaj N, Bissel SJ, Hartman AL, Smith DR. Animal models of Rift Valley fever virus infection. Virus Research 2012 Mar, 163(2): 417-423
Safronetz D, Ebihara H, Feldmann H, Hooper JW. The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Research 2012 Sept, 95(3): 282-92
Sampath R, Mulholland N, Blyn LB, Massire C, Whitehouse CA, Waybright N, Harter C, Bogan J, Miranda MS, Smith D, Baldwin C, Wolcott M, Norwood D, Kreft R, Frinder M, Lovari R, Yasuda I, Matthews H, Toleno D, Housley R, Duncan D, Li F, Warren R, Eshoo MW, Hall TA, Hofstadler SA, Ecker DJ. Comprehensive biothreat cluster identification by PCR/electrospray-ionization mass spectrometry. PLoS One 2012 7(6): e36528
Samy RP, Gopalakrishnakone P, Stiles BG, Girish KS, Swamy SN, Hemshekhar M, Tan KS, Rowan EG, Sethi G, Chow VTK. Snake venom phospholipases A(2): A novel tool against bacterial diseases. Current Medicinal Chemistry 2012 Dec, 19(36): 6150-6162
Samy RP, Rajendran P, Li F, Anandi NM, Stiles BG, Ignacimuthu S, Sethi G, Chow VTK. Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-kappa B pathway. PLoS One 2012 Dec, 7(12): e48514
Schmaljohn C, Mandl CW. The interface of animal and human vaccines. Current Opinion in Virology 2012 June 2(3): 306-308
Schmaljohn CS, Smith LA, Friedlander AM. Military vaccines in today's environment. Human Vaccines & Immunotherapeutics 2012 Aug, 8(8): 1126-1128
Shea A, Wolcott M, Daefler S, Rozak DA. Biolog phenotype microarrays. Methods in Molecular Biology 2012, 881: 331-373
Shipley MA, Koehler JW, Kulesh DA, Minogue TD. Comparison of nucleic acid extraction platforms for detection of select biothreat agents for use in clinical resource limited settings. Journal of Microbiological Methods 2012 Oct, 91(1): 179 - 183
Shurtleff AC, Biggins JE, Keeney AE, Zumbrun EE, Bloomfield HA, Kuehne A, Audet JL, Alfson KJ, Griffiths A, Olinger GG, Bavari S. Standardization of the filovirus plaque assay for use in preclinical studies. Viruses 2012 Dec, 4(12): 3511 -3530
Shurtleff AC, Garza N, Lackemeyer M, Carrion Jr, R, Griffiths A, Patterson J, Edwin SS, Bavari S. The impact of regulations safety considerations and physical limitations on research progress at maximum biocontainment. Viruses 2012 Dec, 4(12): 3932-3951
Shurtleff AC, Nguyen TL, Kingery DA, Bavari S. Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design. Expert Opinion on Drug Discovery 2012 Oct, 7(10): 935- 954
Silva LP, Vanzile M, Bavari S, Aman JMJ, Schriemer DC. Assembly of Ebola virus matrix protein VP40 is regulated by latch-like properties of N and C terminal tails. PLoS One 2012 7(7): e39978
Smith DR, Bird BH, Lewis B, Johnston SC, McCarthy S, Keeney A, Botto M, Donnelly G, Shamblin J, Albarino CG, Nichol ST, Hensley LE. Development of a Novel Nonhuman Primate Model for Rift Valley Fever. Journal of Virology 2012 Feb, 86 (4): 2109-2120
Sobarzo A, Perelman E, Groseth A, Dolnik O, Becker S, Lutwama JJ, Dye JM, Yavelsky V, Lobel L, Marks RS. Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent Assay. Clinical and Vaccine Immunology 2012 Nov, 19(11): 1844-1852
Switzer CH, Cheng RY, Ridnour LA, Murray MC, Tazzari V, Sparatore A, Del Soldato P, Hines HB, Glynn SA, Ambs S, Wink DA. Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Research 2012 May 1; 72(9): 2394-2404
Thomas D, Naughton J, Cote C, Welkos S, Manchester M, Young JAT. Delayed Toxicity Associated with Soluble Anthrax Toxin Receptor Decoy-Ig Fusion Protein Treatment. PLoS One 2012 7(4): e34611
Toth S, Brueggmann EE, Oyler GA, Smith LA, Hines HB, Ahmed SA. Tyrosine phosphorylation of botulinum neurotoxin protease domains. Frontiers in Pharmacology 2012, 3: 102
Turell MJ. Members of the culex pipiens complex as vectors of Viruses. Journal of the American Mosquito Control Association 2012 Apr, 28(4 Suppl): 123-126
Varga JJ, Vigil A, DeShazer D, Waag DM, Felgner P, Goldberg JB. Distinct human antibody response to the biological warfare agent Burkholderia mallei. Virulence 2012 Oct, 3(6): 510-514
Wagner L, Verma A, Meade BD, Reiter K, Narum DL, Brady RA, Little SF, Burns DL. Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant. Clinical and Vaccine Immunology 2012 Sept, 19(9): 1465-1473
Warren TK, Shurtleff AC, Bavari S. Advanced morpholino oligomers: a novel approach to antiviral therapy. Antiviral Research 2012 Apr, 94(1): 80-8
Weinstein SA, Stiles BG. Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium. Expert Review of Anti-infective Therapy 2012 Apr 10(4): 487-99
Whitehouse CA, Kesterson KE, Duncan DD, Eshoo MW, Wolcott M. Identification and characterization of Francisella species from natural warm springs in Utah USA. Letters in Applied Microbiology 2012 Apr, 54(4): 313-324
Wigelsworth DJ, Ruthel G, Schnell L, Herrlich P, Blonder J, Veenstra TD, Carman RJ, Wilkins TD, Guy TVN, Pauillac S, Gibert M, Sauvonnet N, Stiles BG, Popoff MR, Barth H. CD44 Promotes Intoxication by the Clostridial Iota-Family Toxins. PLoS One 2012, 7(12): e51356
Woo HJ Reifman J. A quantitative quasispecies theory-based model of virus escape mutation under immune selection. Proceedings of the National Academy of Sciences of the USA 2012 Aug 7,109(32): 12980-12985
Worsham, PL, Mou S, Cote CK, Fritz D. Virulence of Yersinia pseudotuberculosis in aerosol models. Advances in Experimental Medicine and Biology 2012, 954: 217-222
Yeager John J, Facemire P, Dabisch PA, Robinson CG, Nyakiti D, Beck K, Baker R, Pitt MLM. Natural History of Inhalation Melioidosis in Rhesus Macaques (Macaca mulatta) and African Green Monkeys (Chlorocebus aethiops.) Infection and Immunity 2012 Sept, 80(9): 3332-3340
Zamolo VA, Valenti G, Venturelli E, Chaloin O, Marcaccio M, Boscolo S, Castagnola V, Sosa S, Berti F, Fontanive G, Poli M, Tubaro A, Bianco A, Paolucci F, Prato M. Highly sensitive electrochemiluminescent nanobiosensor for the detection of palytoxin. ACS Nano 2012 Sept. 25, 6(9): 7989-7997
Zumbrun EE, Abdeltawab NF, Bloomfield HA, Chance TB, Nichols DK, Harrison PE, Kotb M, Nalca A. Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice. Viruses 2012 Dec, 4(12): 3468-3493
Zumbrun EE, Bloomfield HA, Dye JM, Hunter TC, Dabisch PA, Garza N,L Bramel NR, Baker RJ, Williams RD, Nichols DK, Nalca A. A characterization of aerosolized sudan virus infection in African green monkeys cynomolgus macaques and rhesus macaques. Viruses 2012 Oct 15, 4(10): 2115 - 2136
|
SITEMAP
ARMY.MIL 
